Improved outcome for Chinese children with acute promyelocytic leukemia: A comparison of two protocols

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 325-328

  Luo, Xue Qun ^a   Ke, Zhi Yong ^a   Huang, Li Bin ^a   Guan, Xiao Qing ^a   Zhang, Ying Chuan ^a   Zhang, Xiao Li ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Acute promyelocytic leukemia; Childhood; Developing countries

Indexed keywords

ANTHRACYCLINE; ARSENIC DERIVATIVE; CHINESE DRUG; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOMPERIDONE; INDIRUBIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; RETINOIC ACID; TANSHINONE IIA;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ATRA SYNDROME; BONE PAIN; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHINESE; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; DRUG FEVER; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG MEGADOSE; EVENING DOSAGE; EVENT FREE SURVIVAL; FEMALE; GENE REARRANGEMENT; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; INFANT; LEUKEMIA RELAPSE; MAINTENANCE THERAPY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SCHOOL CHILD; SEPSIS; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ANTHRACYCLINES; CHILD; CHILD, PRESCHOOL; CYTARABINE; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; TREATMENT OUTCOME; TRETINOIN;

EID: 67651234012     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22042     Document Type: Article

References (22)

1. Avvisati G, Petti MC, Lo-coco F, et al. Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: Final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up. Blood 2002;31:3141-3146. (Pubitemid 35217061)
2. Testi AM, Biondi A, Lo-Coco F, et al. GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood 2005;106:447-453. (Pubitemid 40981236)
3. Ades L, Sanz MA, Chevret S, et al. Treatment of newly diagnosed acute promyelocytic leukemia (APL): A comparison of French-Belgian-Swiss and PETHEMA results. Blood 2008;111:1078-1084. (Pubitemid 351213385)
4. Ades L, Chevret S, Raffoux E, et al. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. J Clin Oncol 2006;24:5703-5710. (Pubitemid 46631312)
5. Ortega JJ, Madero L, Martín G, et al. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: A Multicenter Study by the PETHEMA Group. J Clin Oncol 2005;23:7632-7640. (Pubitemid 46291827)
6. Jácomo RH, Melo RAM, Souto FR, et al. Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines. Haematologica 2007;92: 1431-1432.
7. Ribeiro RC, Rego E. Management of APL in developing countries: Epidemiology, challenges and opportunities for international collaboration. Hematol Am Soc Hematol Educ Program 2006; 162-168.
8. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc (A) 1972;135-206.
9. Fenaus P, Chastang C, Chevert S, et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 1999;94:1192-1200.
10. Tallman MS, Anderson JW, Schiffer CA, et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997;337: 1021-1028. (Pubitemid 27430519)
11. Ghaddar HM, Pierce S, Kantarjian HM, et al. Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia. Leuk Lymphoma 1996;22:71-76. (Pubitemid 26177720)
12. Schlenk RE, Germing U, Hartmann F, et al. High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia 2005;19:978-983. (Pubitemid 40862008)
13. Snaz MA, Martin G, Gonzalez M, et al. Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: A multicenter study by the PETHEMA group. Blood 2004;103:1237-1243. (Pubitemid 38168633)
14. Luo XQ, Ke ZY, Guan XQ, et al. The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China. Pediatr Blood Cancer 2008;51: 204-209.
15. Tang Y, Xu X, Song H, et al. Long-term outcome of childhood acute lymphoblastic leukemia treated in China. Pediatr Blood Cancer 2008;51:380-386.
16. Reamon GH, Altman AJ, editors. Supportive care of children with cancer: Current Guidelines from the Children's Oncology Group. Baltimore, MD: Johns Hopkins University Press; 2004. pp 122-125.
17. Chen X, editor. Manual of clinical medication. Guangzhou, China: Guangdong Science and Technology Press; 2004. pp 284-287 (Chinese).
18. Wang L, Zhou GB, Liu P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci 2008; 105:4826-4831. (Pubitemid 351753831)
19. Huang SL, Guo AX, Xiang Y, et al. Clinical study on the treatment of acute promyelocytic leukemia mainly with Compos-ITE Indigo naturalis tablets. Zhonghua Xue Ye Xue Za Zhi 1995;16:26-28 (Chinese).
20. Sun F, Chen NN, Cheng YB, et al. Compound realgar and natural indigo tablets in treatment of acute promyelocytic leukemia: A summary of experience in 204 cases. Zhong Xi Yi Jie He Xue Bao 2008;6:639-642 (Chinese).
21. Pan D, Huang M, Shi XY. Clinical observation of the short-term efficacy of the treatment with combination of all-trans retinoic acid (ATRA) and composite indigo naturalis tablets in acute promyelocytic leukemia (APL). J Clin Hematol 2007;20:344-346 (Chinese).
22. Xue H, Guo M, Hao SX, et al. Outcome of patients with acute promyelocytic leukemia on post-induction therapy with Chinese medicinal formula Realgar-Indigo naturalis combined with chemotherapy. Clin Focus 2008;23:52-53 (Chinese).